BR112019000820A8 - Formulação tópica - Google Patents

Formulação tópica

Info

Publication number
BR112019000820A8
BR112019000820A8 BR112019000820A BR112019000820A BR112019000820A8 BR 112019000820 A8 BR112019000820 A8 BR 112019000820A8 BR 112019000820 A BR112019000820 A BR 112019000820A BR 112019000820 A BR112019000820 A BR 112019000820A BR 112019000820 A8 BR112019000820 A8 BR 112019000820A8
Authority
BR
Brazil
Prior art keywords
topical formulation
agent
active agent
salvigenin
asiaticoside
Prior art date
Application number
BR112019000820A
Other languages
English (en)
Other versions
BR112019000820A2 (pt
BR112019000820B1 (pt
Inventor
Chen Jen-Wei
Lu Kung-Ming
Original Assignee
Oneness Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oneness Biotech Co Ltd filed Critical Oneness Biotech Co Ltd
Publication of BR112019000820A2 publication Critical patent/BR112019000820A2/pt
Publication of BR112019000820A8 publication Critical patent/BR112019000820A8/pt
Publication of BR112019000820B1 publication Critical patent/BR112019000820B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uma formulação tópica compreendendo um agente ativo, um agente de aumento da viscosidade, uma base de unguento, um conservante antimicrobiano e um agente emulsificante, em que o agente ativo compreende salvigenina e, opcionalmente, asiaticosídeo.
BR112019000820-9A 2016-07-17 2017-07-17 Formulação tópica BR112019000820B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662363284P 2016-07-17 2016-07-17
US62/363,284 2016-07-17
PCT/CN2017/093118 WO2018014805A1 (en) 2016-07-17 2017-07-17 Topical formulation for promoting wound healing

Publications (3)

Publication Number Publication Date
BR112019000820A2 BR112019000820A2 (pt) 2019-04-30
BR112019000820A8 true BR112019000820A8 (pt) 2023-03-28
BR112019000820B1 BR112019000820B1 (pt) 2023-08-15

Family

ID=

Also Published As

Publication number Publication date
KR20190040485A (ko) 2019-04-18
RU2750286C2 (ru) 2021-06-25
BR112019000820A2 (pt) 2019-04-30
MY193312A (en) 2022-10-04
JP2022169590A (ja) 2022-11-09
TWI746597B (zh) 2021-11-21
CA3030774A1 (en) 2018-01-25
PL3484457T3 (pl) 2023-08-14
HUE062184T2 (hu) 2023-09-28
MX2019000769A (es) 2019-09-19
LT3484457T (lt) 2023-07-25
EP3484457A4 (en) 2020-03-18
PH12019500126A1 (en) 2019-04-15
US20180015133A1 (en) 2018-01-18
SG11201900408RA (en) 2019-02-27
RS64356B1 (sr) 2023-08-31
EP3484457B1 (en) 2023-06-28
KR102362362B1 (ko) 2022-02-14
CN108778262A (zh) 2018-11-09
RU2019104255A (ru) 2020-08-18
JP7469400B2 (ja) 2024-04-16
TW201811352A (zh) 2018-04-01
US10758584B2 (en) 2020-09-01
ES2955844T3 (es) 2023-12-07
WO2018014805A1 (en) 2018-01-25
JP2019527219A (ja) 2019-09-26
PT3484457T (pt) 2023-07-05
HRP20230726T1 (hr) 2023-10-13
SI3484457T1 (sl) 2023-08-31
DK3484457T3 (da) 2023-07-10
RU2019104255A3 (pt) 2020-09-03
FI3484457T3 (fi) 2023-07-07
EP3484457A1 (en) 2019-05-22

Similar Documents

Publication Publication Date Title
PH12019500126A1 (en) Topical formulation for promoting wound healing
BR112018015824A2 (pt) composições para higiene pessoal
CL2019000586A1 (es) Composiciones de toxinas clostridiales no proteicas.
CO7240372A2 (es) Formulaciones farmacéuticas tópicas no acuosas
BR112018016174A2 (pt) combinações fungicidas
CO2017001994A2 (es) Compuestos activos hacia bromodominios
BR112015023391A2 (pt) formulações compreendendo conjugado droga-anticorpo anti-egfr
BR112014019290A8 (pt) Aplicadores de tampas combinadas e método
MX2017007829A (es) Composicion antimicrobiana.
BR112017019352A2 (pt) composições tópicas comprimidas a corticosteróide aplicações relacionadas
BR112012023942A2 (pt) curativo para feridas e processo para a preparação de um curativo para feridas.
BR112015011743A2 (pt) conservantes
CO2017007316A2 (es) Formulación farmacéutica
AR048775A1 (es) Un medicamento que comprende ptx3 y un agente antifungico para el tratamiento de infecciones fungicas particularmente aspergilosis
BR112017028137A2 (pt) agente terapêutico para fibrose
BR112017004745A2 (pt) adição a um aplicador médico
CO2017001712A2 (es) Formulaciones de compuestos biológicos para instilación
BR112018014723A2 (pt) fantasmas bacterianos para o tratamento de câncer
CL2019001550A1 (es) Fenytoina tópica para uso en el tratamiento del dolor neuropático periférico.
BR112018010456A8 (pt) ?composição, método para limpeza ou desinfecção de uma superfície e uso de uma composição?
MX2016000116A (es) Formulaciones de compuestos organicos volatiles que tienen actividad antimicrobiana.
AR109407A1 (es) Compuesto de 1-acetil-3-fenilurea y su uso
AR106221A1 (es) Una composición de toxicidad baja
BR112018005268A2 (pt) nanopartículas não vesiculares altamente estáveis e aplicação das mesmas no tratamento de infecção microbiana”
AR109406A1 (es) Compuesto de 1-fenil-3-carbamoilurea y su uso

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 31/02 , A61K 31/704 , A61K 36/28 , A61K 36/18 , A61K 9/06

Ipc: A61K 36/53 (2006.01), A61K 36/23 (2006.01), A61K 3

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/07/2017, OBSERVADAS AS CONDICOES LEGAIS